AAAAAA

   
Results: 1-9 |
Results: 9
IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE
Authors: HAUBRICH R LALEZARI J FOLLANSBEE SE GILL MJ HIRSCH M RICHMAN D MILDVAN D BURGER HU BEATTIE D DONATACCI L SALGO MP
Citation: R. Haubrich et al., IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE, Antiviral therapy, 3(1), 1998, pp. 33-42
SELECTING THE OPTIMUM DOSE FOR A NEW SOFT GELATIN CAPSULE FORMULATIONOF SAQUINAVIR
Authors: LALEZARI J
Citation: J. Lalezari, SELECTING THE OPTIMUM DOSE FOR A NEW SOFT GELATIN CAPSULE FORMULATIONOF SAQUINAVIR, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 195-197
RELATIVE RISK ASSESSMENT OF RETINAL-DETACHMENT OR ENDOPHTHALMITIS WITH INTRAVITREAL INJECTIONS OF EYES WITH CMV RETINITIS
Authors: BOYER D CANTRILL H JAFFE G KUPPERMANN B LALEZARI J LAMBERT M LIEBERMAN R PARK S TERRY B
Citation: D. Boyer et al., RELATIVE RISK ASSESSMENT OF RETINAL-DETACHMENT OR ENDOPHTHALMITIS WITH INTRAVITREAL INJECTIONS OF EYES WITH CMV RETINITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3412-3412
THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DEEKS SG COLLIER A LALEZARI J PAVIA A RODRIGUE D DREW WL TOOLE J JAFFE HS MULATO AS LAMY PD LI WX CHERRINGTON JM HELLMANN N KAHN J
Citation: Sg. Deeks et al., THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(6), 1997, pp. 1517-1523
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CIDOFOVIR GELFOR THE TREATMENT OF ACYCLOVIR-UNRESPONSIVE MUCOCUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN PATIENTS WITH AIDS
Authors: LALEZARI J SCHACKER T FEINBERG J GATHE J LEE S CHEUNG T KRAMER F KESSLER H COREY L DREW WL BOGGS J MCGUIRE B JAFFE HS SAFRIN S
Citation: J. Lalezari et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CIDOFOVIR GELFOR THE TREATMENT OF ACYCLOVIR-UNRESPONSIVE MUCOCUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN PATIENTS WITH AIDS, The Journal of infectious diseases, 176(4), 1997, pp. 892-898
ANTIRETROVIRAL MONOTHERAPY IN EARLY-STAGE HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE HAS NO DETECTABLE EFFECT ON VIRUS LOAD IN PERIPHERAL-BLOOD AND LYMPH-NODES
Authors: COHEN OJ PANTALEO G HOLODNIY M FOX CH ORENSTEIN JM SCHNITTMAN S NIU M GRAZIOSI C PAVLAKIS GN LALEZARI J BARTLETT JA STEIGBIGEL RT COHN J NOVAK R MCMAHON D BILELLO J FAUCI AS
Citation: Oj. Cohen et al., ANTIRETROVIRAL MONOTHERAPY IN EARLY-STAGE HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE HAS NO DETECTABLE EFFECT ON VIRUS LOAD IN PERIPHERAL-BLOOD AND LYMPH-NODES, The Journal of infectious diseases, 173(4), 1996, pp. 849-856
FAILURE OF HIGH-DOSE ORAL ACYCLOVIR TO SUPPRESS CMV VIRURIA OR INDUCEGANCICLOVIR-RESISTANT CMV IN HIV ANTIBODY-POSITIVE PATIENTS
Authors: DREW WL ANDERSON R LANG W MINER RC DAVIS G LALEZARI J
Citation: Wl. Drew et al., FAILURE OF HIGH-DOSE ORAL ACYCLOVIR TO SUPPRESS CMV VIRURIA OR INDUCEGANCICLOVIR-RESISTANT CMV IN HIV ANTIBODY-POSITIVE PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 289-291
HIV-1 RESISTANCE MUTATIONS AND PLASMA RNA DURING ZIDOVUDINE PLUS ZALCITABINE COMBINATION THERAPY
Authors: SYLVESTER A CALIENDO A AN D SAVARA A BYINGTON R STRICK D LILLANEY R SUTTON L SEPKOWITZ K FISCHL M SIMON G LALEZARI J MITSUYASU R DAQUILA R
Citation: A. Sylvester et al., HIV-1 RESISTANCE MUTATIONS AND PLASMA RNA DURING ZIDOVUDINE PLUS ZALCITABINE COMBINATION THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 47-47
DECREASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PLASMA VIREMIA DURING ANTIRETROVIRAL THERAPY REFLECTS DOWN-REGULATION OF VIRAL REPLICATION INLYMPHOID-TISSUE
Authors: COHEN OJ PANTALEO G HOLODNIY M SCHNITMAN S NIU M GRAZIOSI C PAVLAKIS GN LALEZARI J BARTLETT JA STEIGBIGEL RT COHN J NOVAK R MCMAHON D FAUCI AS
Citation: Oj. Cohen et al., DECREASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PLASMA VIREMIA DURING ANTIRETROVIRAL THERAPY REFLECTS DOWN-REGULATION OF VIRAL REPLICATION INLYMPHOID-TISSUE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(13), 1995, pp. 6017-6021
Risultati: 1-9 |